| Drug Name: | Naratriptan (121679-13-8) |
|---|---|
| PubChem ID: | 4440 |
| SMILES: | CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C |
| InchiKey: | AMKVXSZCKVJAGH-UHFFFAOYSA-N |
| Therapeutic Category: | Cardiovascular Agents, Neurotransmitter Agents, Serotonin 5-HT1 Receptor Agonists, Serotonin Agents, Serotonin Receptor Agonists, Vasoconstrictor Agents |
| Molecular Weight (dalton) | : | 335.473 |
| LogP | : | 2.0688 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 65.2 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category